Advisors Asset Management Inc. cut its stake in shares of Mylan N.V. (NASDAQ:MYL) by 11.8% in the 3rd quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The institutional investor owned 64,541 shares of the company’s stock after selling 8,629 shares during the quarter. Advisors Asset Management Inc.’s holdings in Mylan were worth $2,025,000 as of its most recent SEC filing.

A number of other hedge funds and other institutional investors have also added to or reduced their stakes in MYL. State of Alaska Department of Revenue increased its holdings in Mylan by 49.2% in the 2nd quarter. State of Alaska Department of Revenue now owns 7,222 shares of the company’s stock worth $280,000 after buying an additional 2,380 shares in the last quarter. Aperio Group LLC increased its holdings in Mylan by 18.7% in the 2nd quarter. Aperio Group LLC now owns 128,293 shares of the company’s stock worth $4,980,000 after buying an additional 20,223 shares in the last quarter. Clear Harbor Asset Management LLC bought a new stake in Mylan in the 2nd quarter worth about $215,000. Strs Ohio increased its holdings in Mylan by 69.8% in the 2nd quarter. Strs Ohio now owns 436,000 shares of the company’s stock worth $16,925,000 after buying an additional 179,182 shares in the last quarter. Finally, Public Employees Retirement Association of Colorado increased its holdings in Mylan by 2.6% in the 2nd quarter. Public Employees Retirement Association of Colorado now owns 88,543 shares of the company’s stock worth $3,437,000 after buying an additional 2,262 shares in the last quarter. Institutional investors own 73.35% of the company’s stock.

Mylan N.V. (MYL) opened at $37.37 on Monday. The company has a quick ratio of 0.95, a current ratio of 1.46 and a debt-to-equity ratio of 1.05. Mylan N.V. has a twelve month low of $29.39 and a twelve month high of $45.87. The company has a market capitalization of $20,046.61, a P/E ratio of 7.95, a P/E/G ratio of 2.05 and a beta of 1.38.

Mylan (NASDAQ:MYL) last posted its quarterly earnings results on Monday, November 6th. The company reported $1.10 EPS for the quarter, missing the Zacks’ consensus estimate of $1.20 by ($0.10). Mylan had a return on equity of 20.63% and a net margin of 7.28%. The business had revenue of $2.99 billion during the quarter, compared to analysts’ expectations of $3.09 billion. During the same period in the prior year, the firm posted $1.38 earnings per share. The firm’s revenue for the quarter was down 2.3% on a year-over-year basis. analysts anticipate that Mylan N.V. will post 4.56 earnings per share for the current year.

Several research analysts have issued reports on the company. Zacks Investment Research cut Mylan from a “buy” rating to a “hold” rating in a research report on Wednesday, November 8th. Royal Bank Of Canada raised their target price on Mylan from $32.00 to $37.00 and gave the stock a “sector perform” rating in a research report on Tuesday, November 7th. Cantor Fitzgerald set a $34.00 target price on Mylan and gave the stock a “hold” rating in a research report on Tuesday, October 31st. BidaskClub raised Mylan from a “hold” rating to a “buy” rating in a research report on Friday, October 27th. Finally, Mizuho reissued a “buy” rating and issued a $37.00 target price on shares of Mylan in a research report on Tuesday, October 24th. One research analyst has rated the stock with a sell rating, eight have given a hold rating and thirteen have assigned a buy rating to the stock. The company presently has a consensus rating of “Buy” and a consensus target price of $41.49.

TRADEMARK VIOLATION NOTICE: “Advisors Asset Management Inc. Has $2.03 Million Stake in Mylan N.V. (MYL)” was first reported by Watch List News and is the sole property of of Watch List News. If you are viewing this piece of content on another publication, it was illegally copied and reposted in violation of US & international copyright and trademark law. The legal version of this piece of content can be viewed at https://www.watchlistnews.com/advisors-asset-management-inc-has-2-03-million-stake-in-mylan-n-v-myl/1728592.html.

Mylan Profile

Mylan N.V. is a global pharmaceutical company. The Company develops, licenses, manufactures, markets and distributes generic and branded generic products for resale by others; specialty pharmaceuticals, and active pharmaceutical ingredients (APIs). It operates through two segments: Generics and Specialty.

Institutional Ownership by Quarter for Mylan (NASDAQ:MYL)

Receive News & Ratings for Mylan N.V. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Mylan N.V. and related companies with Analyst Ratings Network's FREE daily email newsletter.